Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment

Clinical Rheumatology

Volumn 21, Issue 5, 2002, Pages 363-368

  Wang, S J ^a   Yang, Y H ^a   Lin, Y T ^a   Yang, C M ^a   Chiang, B L ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adult height; Corticosteroid; Juvenile rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG POTENCY; DRUG USE; FEMALE; GROWTH DISORDER; HOSPITALIZATION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LINEAR REGRESSION ANALYSIS; LONG TERM CARE; MALE; PARENT; PATIENT CODING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ARTHRITIS, JUVENILE RHEUMATOID; BODY HEIGHT; CASE-CONTROL STUDIES; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HUMANS; LINEAR MODELS; MALE; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TAIWAN;

EID: 0036741149     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670200098     Document Type: Article

References (41)

1. Lipnick RN, Tsokos GC. Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis. Clin Exp Rheumatol 1990;8:177-86.
2. Ostrov BE. Nutrition and pediatric rheumatic diseases. Hypothesis: cytokines modulate nutritional abnormalities in rheumatic diseases. J Rheumatol 1992;19:(Suppl 33):49-53.
3. Prieur AM. The place of corticosteroid therapy in juvenile chronic arthritis in 1992. J Rheumatol 1993;20(Suppl 37):32-4.
4. Cassidy JT, Petty RE. Textbook of pediatric rheumatology, 3rd edn. Philadelphia: WB Saunders, 1995:133-223.
5. Bernstein BH, Stobie D, Singsen BH, Koster-King K, Kornreich HK, Hanson V. Growth retardation in juvenile rheumatoid arthritis. Arthritis Rheum 1997;20:212-16.
6. Woo PMM. Growth retardation and osteoporosis in juvenile chronic arthritis. Clin Exp Rheumatol 1994;12(Suppl 10):87-90.
7. Hughes IA. Steroids and growth. Br Med J 1987;295:683-4.
8. Hyams JS, Carey DE. Corticosteroids and growth. J Pediatr 1988;113;249-54.
9. Tanner JM. Fetus into man: physical growth from conception to maturity. London: Open Books, 1978.
10. Polito C, Strano CG, Olivieri AN et al. Growth retardation in non-steroid treated juvenile rheumatoid arthritis. Scand J Rheumatol 1997;26:99-103.
11. Falcini F, Taccetti G, Trapani S, Tafi L, Volpi M. Growth retardation in juvenile chronic arthritis patients treated with steroids. Clin Exp Rheumatol 1991;9(Suppl 6):37-40.
12. Bacon MC, White pH, Raiten DJ et al. Nutritional status and growth in juvenile rheumatoid arthritis. Semin Arthritis Rheum 1990;20:97-106.
13. Cavalieri F, Salaffi F, Ferraccioli GF. Relationship between physical impairment, psychological variables and pain in rheumatoid disability. An analysis of their relative impact. Clin Exp Rheumatol 1991;9:47-50.
14. Martini A, Ravelli A, Notarangelo LD et al. Enhanced interleukin 1 and Depressed interleukin 2 production in juvenile arthritis. J Rheumatol 1986;13:598-603.
15. Woo P. Cytokines in childhood rheumatic diseases. Arch Dis Child 1993;69:547-9.
16. Tracey KJ, Wei H, Manogue KR et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988-167:1211- 27.
17. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987;316:379-85.
18. Kotaniemi A, Savolainen A, Kröger H, Kautianen H, Isomäki H. Development of bone mineral density at the lumbar spine and femoral neck in juvenile chronic arthritis- a prospective one year followup study. J Rheumatol 1998;25:2450-5.
19. Kotaniemi A. Growth retardation and bone loss as determinants of axial osteopenia in juvenile chronic arthritis. Scand J Rheumatol 1997;26:14-18.
20. Bijlsma JMJ. Bone metabolism in patients with rheumatoid arthritis. Clin Rheumatol 1988;7:16-23.
21. Polito C, Strano CG, Rea L et al. Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis. Ann Rheum Dis 1995;54:193-6.
22. Cassidy JT, Hillman LS. Abnormalities in skeletal growth in children with juvenile rheumatoid arthritis. Rheum Dis Clin North Am 1997;23:499 522.
23. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
24. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987;138:464-8.
25. Jilka RL, Hangoc G, Girasole G et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;257;88-91.
26. Shinmei M, Masuda K, Kikuchi T, Shimomura Y. Interleukin 1, tumor necrosis factor, and interleukin 6 as mediators of cartilage destruction. Semin Arthritis Rheum 1989;18:27-32.
27. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986;319:516-8.
28. Allen RC, Jimenez M, Cowell CT. Insulin-like growth factor and growth hormone secretion in juvenile chronic arthritis. Ann Rheum Dis 1991;50:602-6.
29. Aitman TJ, Palmer RG, Loftus J et al. Serum IGF-I levels and growth failure in juvenile chronic arthritis. Clin Exp, Rheumatol 1989;7:557-61.
30. Bennett AE, Silverman ED, Miller JJ, Hintz RL. Insulin-like growth factors I and II in children with systemic onset juvenile arthritis. J Rheumatol 1988;15:655-8.
31. Benedetti FD, Alonzi T, Moretta A et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-1. J Clin Invest 1997;99:643 50.
32. Blodgett FM, Burgin L, Iezzoni D, Gribetz D, Taldot NB. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. N Engl J Med 1956;254:636-41.
33. Stanbury RM, Graham EM. Systemic corticosteroid therapy - side effects and their management. Br J Ophthalmol 1998;82:704-8.
34. Kotaniemi A, Savolainen A, Kautiainen H, Kröger H. Estimation of central osteopenia in children with chronic polyarthritis treated with glucocorticoids. Pediatrics 1993;91:1127-30.
35. Saha MT, Verronen P, Laippala P, Lenko HL. Growth of prepubertal children with juvenile chronic arthritis. Acta Pediatr 1999-88:724-8.
36. Morris HG. Growth and skeletal maturation in asthmatic children: effect of corticosteroid treatment. Pediatr Res 1975;9:579-83.
37. Chang KC, Miklich DR, Barwise G, Chai H, Miles-Lawrence R. Linear growth of chronic asthmatic children: the effects of the disease and various forms of steroid therapy. Clin Allergy 1982;12:369-78.
38. Rees L, Greene SA, Adlard P et al. Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child 1988;63:484-90.
39. McCaffery TD, Nasr K, Lawrence AM, Kirsner JB. Severe growth retardation in children with inflammatory bowel disease. Pediatrics 1970;45:386-93.
40. Lam CN, Arneil GC. Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis. Arch Dis Child 1968;43:589-94.
41. Prader A, Tanner JM, von Harnack G. Catch-up growth following illness or starvation. J Pediatr 1963;62:646-59.